Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.

Signal transduction by receptors with tyrosine kinase activity

Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435

Gene Splicing by Overlap Extension: Tailor-Made Genes Using the Polymerase Chain Reaction

Horton, R. M., Cai, Z., Ho, S. N., & Pease, L. R. (2013) · BioTechniques · doi:10.2144/000114017 · Cited by 1,292

Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation

Egan, S. E., Giddings, B. W., Brooks, M. W., Buday, L., Sizeland, A. M., & Weinberg, R. A. (1993) · Nature · doi:10.1038/363045a0 · Cited by 1,200

[42] Detection and quantification of phosphotyrosine in proteins

Cooper, J. A., Sefton, B. M., & Hunter, T. R. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)99075-4 · Cited by 1,109

Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor

Buday, L., & Downward, J. (1993) · Cell · doi:10.1016/0092-8674(93)90146-h · Cited by 1,064

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

Rozakis-Adcock, M., Fernley, R. T., Wade, J. D., Pawson, T. J., & Bowtell, D. D. L. (1993) · Nature · doi:10.1038/363083a0 · Cited by 1,009

Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation.

Backer, J., Myers, M. G., Shoelson, S. E., Chin, D. J., Sun, X., Miralpeix, M., Hu, P. J., Margolis, B. L., Skolnik, E. Y., & Schlessinger, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05426.x · Cited by 1,000

Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases

Rozakis-Adcock, M., McGlade, J. C., Mbamalu, G., Pelicci, G., Daly, R. J., Li, W., Batzer, A., Thomas, S. Μ., Brugge, J. S., Pelicci, P. G., et al. (1992) · Nature · doi:10.1038/360689a0 · Cited by 973

SH2 and SH3 domains: From structure to function

Pawson, T. J., & Gish, G. D. (1992) · Cell · doi:10.1016/0092-8674(92)90504-6 · Cited by 940

Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling

Li, N., Batzer, A., Daly, R. J., Yajnik, V., Skolnik, E. Y., Chardin, P., Bar‐Sagi, D., Margolis, B. L., & Schlessinger, J. (1993) · Nature · doi:10.1038/363085a0 · Cited by 938

The E5 gene product of rhesus papillomavirus is an activator of endogenous Ras and phosphatidylinositol-3′-kinase in NIH 3T3 cells

Ghai, J., Ostrow, R. S., Tolar, J., McGlennen, R. C., Lemke, T. D., Tobolt, D. K., Liu, Z., & Faras, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12879 · Cited by 16

Association of the Tyrosine Phosphatase SHP‐2 with Transducin‐α and a 97‐kDa Tyrosine‐Phosphorylated Protein in Photoreceptor Rod Outer Segments

Bell, M. W., Alvarez, K. M., & Ghalayini, A. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732331.x · Cited by 16

The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1‐PDGFRα and PDGFRα D842V

Noël, L. A., Arts, F. A., Montano‐Almendras, C. P., Cox, L., Gielen, O., Toffalini, F., Marbehant, C. Y., Cools, J., & Demoulin, J. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.003 · Cited by 16

SHP2 REGULATES IL-2 INDUCED MAPK ACTIVATION, BUT NOT Stat3 OR Stat5 TYROSINE PHOSPHORYLATION, IN CUTANEOUS T CELL LYMPHOMA CELLS

Brockdorff, J. L., Woetmann, A., Mustelin, T., Kaltoft, K., Zhang, Q., Wasik, M. A., Röpke, C., & Ødum, N. (2002) · Cytokine · doi:10.1006/cyto.2002.1986 · Cited by 16

NMR in integrated biophysical drug discovery for RAS: past, present, and future

Marshall, C. B., KleinJan, F., Gebregiworgis, T., Lee, K., Fang, Z., Eves, B. J., Liu, N. F., Gasmi-Seabrook, G. M. C., Enomoto, M., & Ikura, M. (2020) · Journal of Biomolecular NMR · doi:10.1007/s10858-020-00338-6 · Cited by 15

Expression and significance of SHP-2 in human papillomavirus infected cervical cancer

Meng, F., Zhao, X., & Zhang, S. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0044-4 · Cited by 14

Role of PTPN11 (SHP2) in Cancer

Chan, G., & Neel, B. G. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_4 · Cited by 13

Биологические функции shp2 при заболеваниях человека

Li, S., & Li, S. (2016) · Molecular Biology · doi:10.7868/s0026898416010110 · Cited by 14

Clathrin-Independent Endocytosis and Signalling of Interleukin 2 Receptors

Gesbert, F., Sauvonnet, N., & Dautry‐Varsat, A. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69494-6_5 · Cited by 14

Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant

Merritt, R. L., Hayman, M. J., & Agazie, Y. M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.11.013 · Cited by 14

Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility

Brown, C., Lin, Y., & Hassid, A. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.4.h1598 · Cited by 14

The role of Src homology 2 containing protein tyrosine phosphatase 2 in vascular smooth muscle cell migration and proliferation

Kandadi, M. R., Stratton, M. S., & Ren, J. T. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.168 · Cited by 13

Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2

Šolman, M., Woutersen, D. T. J., & den Hertog, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1046415 · Cited by 14

Protein tyrosine kinase 6 regulates activation of SRC kinase

Alwanian, W. M., Vlajic, K., Bie, W., Kajdacsy-Balla, A., & Tyner, A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102584 · Cited by 11

Imaging flow cytometry and GST pulldown assays provide new insights into channel catfish leukocyte immune-type receptor-mediated phagocytic pathways

Zwozdesky, M. A., Fei, C., Lillico, D. M. E., & Stafford, J. L. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.10.011 · Cited by 12

Complex Roles of PTPN11/SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy

Scheiter, A., Lu, L., Gao, L. H., & Feng, G. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062722-013740 · Cited by 13

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network

Wu, X., Wang, L., Pearson, N. A., Renuse, S., Cheng, R., Liang, Y., Mun, D., Madugundu, A. K., Xu, Y., Gill, P. S., et al. (2021) · Cancers · doi:10.3390/cancers13164234 · Cited by 9

Protein Tyrosine Phosphatase Inhibitors in FcγRI-Induced Myeloid Oxidant Signaling

Erdreich‐Epstein, A., Liu, M., Liu, Y., & Durden, D. L. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3795 · Cited by 11

Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia

He, C., Peng, Z., Zhang, D., Guo, Y., Liang, T., Zhao, Y., Yu, L., Zhang, Q., Chang, Z., Xiao, Y., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115588 · Cited by 10

Hematopoietic Colony Formation from Human Growth Factor-Dependent TF1 Cells and Human Cord Blood Myeloid Progenitor Cells Depends on SHP2 Phosphatase Function

Broxmeyer, H. E., Etienne‐Julan, M., Gotoh, A., Braun, S. E., Lu, L., Cooper, S. H., Feng, G., Li, X. J., & Chan, R. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0478 · Cited by 10

A shift in the IL-6/STAT3 signalling pathway imbalance towards the SHP2 pathway in severe asthma results in reduced proliferation process

Salem, I. H., Plante, S., GOUNNI, A. S., Rouabhia, M., & Chakir, J. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.12.001 · Cited by 10

ALK-Positive Non-Small Cell Lung Cancer; Potential Combination Drug Treatments

Shrestha, N., & Ashton, J. C. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210729100647 · Cited by 9

Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatases

Chiarugi, P., Taddei, M. L., & Ramponi, G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4448-1 · Cited by 10

Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cells

Kim, S.-M., Kwon, E., Kim, Y.-J., Go, Y.-H., Oh, J., Park, S., Tae, J., Kim, K.-T., & Cha, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02976-z · Cited by 9

Selective Regulation of Cytoskeletal Dynamics and Filopodia Formation by Teleost Leukocyte Immune-Type Receptors Differentially Contributes to Target Capture During the Phagocytic Process

Lillico, D. M. E., Pemberton, J. G., & Stafford, J. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01144 · Cited by 9

The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2

Minoo, P., Chughtai, N., Campiglio, M., Stein-Gerlach, M., Lebrun, J. J., Ullrich, A., & Ali, S. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00122-5 · Cited by 9

Expression of transfected human Na+/H+ exchanger (NHE-1) in the basolateral membrane of opossum kidney cells

Takaichi, K., Miyajima, Y., Hanai, J., Kurokawa, K., Fujita, T., & Warnock, D. G. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199901)178:1 · Cited by 2

Signaling by ectopically expressed Drosophila Src64 requires the protein-tyrosine phosphatase corkscrew and the adapter downstream of receptor kinases.

Cooper, J. A., Simon, M. A., & Kussick, S. J. (1996) · PubMed · Cited by 8

Posttranslational modifications remodel proteome-wide ligandability

Li, W., Wei, Q., Llanos, M. A., Gathmann, C., Governa, P., Chiu, T.-Y., Wozniak, J. M., Jadhav, A. M., Holcomb, M., Cravatt, J. B., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02216-y · Cited by 9

SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD

Lee, S., Kim, J., Ryu, H.-H., Jang, H.-B., Lee, D., Lee, S., Song, J., Lee, Y., & Suh, Y. H. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316819121 · Cited by 7

Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis

Chen, C., Tseng, P., Satria, R. D., Nguyen, T. T. D., Tsai, C., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094669 · Cited by 7

Growth Factors Stimulate Tyrosine Dephosphorylation of p75 and Its Dissociation from the SH2 Domain of Grb2

Lim, Y. P., Low, B. C., Ong, S. H., & Guy, G. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29892 · Cited by 7

Efficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling oncogenic RAS, RAS-GTP dependent oncogenic BRAF and NF1 lossPreprint

Nichols, R. J., Haderk, F., Stahlhut, C. E., Schulze, C. J., Hemmati, G., Wildes, D. P., Tzitzilonis, C., Mordec, K., Marquez, A., Romero, J. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/188730 · Cited by 7

PTPN11 in cartilage development, adult homeostasis, and diseases

Yang, W., & Lefebvre, V. (2025) · Bone Research · doi:10.1038/s41413-025-00425-0 · Cited by 8

Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy

Lu, J., Yu, D., Li, H., Qin, P., Chen, H., & Chen, L. (2024) · Phytotherapy Research · doi:10.1002/ptr.8185 · Cited by 6

Development and validation of machine learning models for the prediction of SH-2 containing protein tyrosine phosphatase 2 inhibitors

Adhikari, N., & Ayyannan, S. R. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10710-x · Cited by 6

Shp2 is involved in neuronal differentiation of hippocampal precursor cells

Kim, H., Han, A. M., Shim, J. H., Yoon, H. H., Kwon, H., & Kwon, Y. K. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02977638 · Cited by 6

The RAS-Regulated RAF-MEK1/2-ERK1/2 Protein Kinase Pathway: The Path Most Traveled in RASopathies

Dutkiewicz, R., Sharpe, H. J., & Cook, S. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-62945-7_18 · Cited by 5

DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels

Tlili, A., Noll, C., Middendorp, S., Duchon, A., Jouan, M., Benabou, E., Hérault, Y., Paul, J., Delabar, J. M., & Janel, N. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.07.014 · Cited by 6

From Stem to Sternum: The Role of Shp2 in the Skeleton

Jensen, N. R., Kelly, R. R., Kelly, K. D., Khoo, S. K., Sidles, S. J., & LaRue, A. C. (2022) · Calcified Tissue International · doi:10.1007/s00223-022-01042-3 · Cited by 4

Analyzing protein tyrosine phosphatases by phosphotyrosine analog integration

Shen, K. (2007) · Methods · doi:10.1016/j.ymeth.2007.03.003 · Cited by 4

SH2-Domain-Containing Protein–Tyrosine Phosphatases

Neel, B. G., Gu, H., & Pao, L. I. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50479-4 · Cited by 4

Dose-Dependent Activation of p21 ras by IFN-β

Berger, L., Tamir, A., Ben‐David, Y., & Hawley, R. G. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.757 · Cited by 4

A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance

Karunaraj, P., Scheele, R., Wells, M. L., Rathod, R., Gokulu, I. S., Abrahamson, S. R., Taylor, L., Chowdhury, L., Kazmi, A., Song, W., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70060-8 · Cited by 7

Development of a Peptide Inhibitor Targeting the C‐SH2 Domain of the SHP2 Phosphatase

Kiani, A., Pierotti, C. L., Schedel, F., Kokot, T., Weyershaeuser, J., Brehm, M., Ríos, P., Fehrenbach, K., Warscheid, B., Minguet, S., et al. (2025) · ChemBioChem · doi:10.1002/cbic.202400938 · Cited by 3

Counteracting immunotyrosine-based signaling motifs augment zebrafish leukocyte immune-type receptor-mediated phagocytic activity

Niemand, R. R., & Stafford, J. L. (2023) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2023.105121 · Cited by 3

PDGF and FGF receptors in health and disease

Fantl, W. J., Williams, L. T., & Peters, K. G. (1996) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(96)80009-7 · Cited by 3

Cloning and expression of the chicken protein tyrosine phosphatase SH-PTP2

Park, C. Y., LaMontagne, K. R., Tonks, N. K., & Hayman, M. J. (1996) · Gene · doi:10.1016/0378-1119(96)00278-8 · Cited by 3

SHP2 Inhibition Abrogates MEK inhibitor Resistance in Multiple Cancer ModelsPreprint

Fedele, C., Ran, H., Diskin, B., Wei, W., Jen, J., Araki, K. Y., Simeone, D. M., Miller, G., Neel, B. G., & Tang, K. H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/307876 · Cited by 3

Time resolved quantitative phosphoproteomics reveals distinct patterns of SHP2 dependence in EGFR signalingPreprint

Vemulapalli, V., Chylek, L. A., Erickson, A. R., LaRochelle, J. R., Subramanian, K., Mohseni, M., LaMarche, M. J., Acker, M. G., Sorger, P. K., Gygi, S. P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/598664 · Cited by 3

STATs in the Central Nervous System

Bonni, A. (2003) · Springer eBooks · doi:10.1007/978-94-017-3000-6_42 · Cited by 2

Tyrosine phosphatases: cellular functions and therapeutic potential

Klann, A. G., Miller, R. A., Norman, E. D., & Klann, E. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.675 · Cited by 2

Cloning and Expression of Chicken Protein Tyrosine Phosphatase Gamma

Xiong, Q., Guo, X., Zong, C. S., Jong, S.-M. J., Jiang, Y., Chan, J. L. ‐., & Wang, L. (1996) · Journal of Biomedical Science · doi:10.1007/bf02253706 · Cited by 2

gp130-mediated signalling as a therapeutic target

Ohtani, T., Ishihara, K., Atsumi, T., Yoshida, Y., Nishida, K., Narimatsu, M., Shirogane, T., Hibi, M., & Hirano, T. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.4.459 · Cited by 2

Additive effects on craniofacial development upon conditional ablation of PDGFRα and SHP2 in the mouse neural crest lineage

Fuhr, D., Johnston, J., Brooks, E. P., & Fantauzzo, K. A. (2025) · Developmental Dynamics · doi:10.1002/dvdy.70099 · Cited by 1

Signaling by insulin receptors and related protein tyrosine kinases

Ouwens, D. M., & Maassen, J. A. (1996) · Biomedical Reviews · doi:10.14748/bmr.v5.180 · Cited by 1

SHP2 : une cible potentielle d’intérêt dans l’obésité et ses complications métaboliques ?

Tajan, M., Édouard, T., Valet, P., & Yart, A. (2016) · Obésité · doi:10.1007/s11690-015-0511-8 · Cited by 1

The Role of Platelet Derived Growth Factor (PDGF) and Its Receptors in Cancer and Metastasis

Feigelson, S. W., Fitzer‐Attas, C. J., & Eisenbach, L. (2001) · Cancer metastasis · doi:10.1007/0-306-48399-8_8 · Cited by 1

The Terminal Gene Hierarchy of Drosophila and the Genetic Control of Tissue Specification and Morphogenesis

Yip, M. L. R., & Lipshitz, H. D. (1996) · Advances in developmental biology · doi:10.1016/s1566-3116(08)60017-1 · Cited by 1

SOCS Proteins and Cytokine Signalling: The many Faces of the SOCS Box

Piessevaux, J. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 1

RAS

Hesketh, R. (1997) · Elsevier eBooks · doi:10.1016/b978-012344548-3/50063-7 · Cited by 1

High-throughput biochemical phenotyping of SHP2 variants reveals the molecular basis of diseases and allosteric drug inhibitionPreprint

Lee, A. A., Mokhtari, D. A., Egan, E. D., Blacklow, S. C., Herschlag, D., & Fordyce, P. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.30.715055 · Cited by 1

LNGCN: a distance-aware continuous-time graph framework for PPI prioritization in experimental screeningPreprint

Xiao, Y., 郑一凡, Hua, Y., Peng, J., Liu, J., Qu, Y., Xu, J., Fu, R., Qian, Q., Košař, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.30.721835 · Cited by 1

SHP2 binds directly to SOS1 to enable RAS activationPreprint

Araki, T., Agrawal, Y., Katti, S. S., Nguyen, H. L. D., Yeggoni, D. P., Geer, M. J., Wei, W., Woutersen, D. T. J., Bijlsma, T., Lian, C. G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731952 · Cited by 3

The role of Src-homology 2 domain containing tyrosine phosphatase 2 in growth factor dependent endothelial signalling and angiogenesis

Mannell, H. (2007) · doi:10.5282/edoc.7096

Chapter 6 Molecular basis of insulin action

Waters, S. B., Holt, K. H., Olson, A. L., & Pessin, J. E. (1997) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(97)80037-3

The role of granulocyte colony-stimulating factor receptor signaling in neutrophil development

de Koning, J. (1999)

Chapter 11 Interaction of pulmonary endothelial cells with blood elements

Wang, Q., Kang, I., & Doerschuk, C. M. (2005) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(05)35011-9

Identification of a Potent Apoptotic Peptide by Fibroblasts: Studies Toward the Design of a Novel Agent for Breast Cancer Therapy

Petti, L. M. (2005) · doi:10.21236/ada443024

Biochemie und Molekulargenetik 1994

Schomburg, D., & Niefind, K. (1995) · Nachrichten aus Chemie Technik und Laboratorium · doi:10.1002/nadc.19950430210

Deciphering a Kit-Shp2-Kit Axis in Regulation of Adult Hematopoietic Stem and Progenitor Cells

Zhu, H. (2011) · eScholarship (California Digital Library)

Dissection of α6β4 Integrin-Dependent Signaling and Breast Carcinoma Invasion: A Dissertation

Yang, X. (2011) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/k2m9-am39

Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1300 Modulation of PDGF Receptor Signaling via the Phosphatase SHP-2 and the Docking Protein Gab1

Kallin, A. (2003)

Intracellular Signaling Networks in the Immune Response: Pathways Activated by Interleukin-2 and-4 Receptors and Their Roles in T Cell Proliferation

Comfort, K. K. (2006)

Signaling Pathways Activated by Interleukin-2 and Interluekin-4 Receptors Mediate T Lymphocyte Clonal Expansion

Comfort, K. K. (2007)

The Molecular Pathogenesis of Noonan Syndrome-Associated RAF1 Mutations

Wu, X. (2014) · TSpace (University of Toronto)

Role of ceacam1 and shp1 in the regulation of insulin sensitivity and hepatic glucose and lipid metabolism

Xu, E. (2012) · Corpus Université Laval (Université Laval)

Modulation of PDGF receptor signaling via the phosphatase SHP-2 and the docking protein Gab1.

Kallin, A. (2003) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cellsPreprint

Kim, S. M., Kwon, E., Kim, Y.-J., Go, Y.-H., Oh, J., Park, S., Tae, J., Kim, K.-T., & Cha, H. (2021) · Research Square · doi:10.21203/rs.3.rs-727080/v1

Molecular Basis for Phosphate Signaling by Prokaryotic and Eukaryotic Phosphatases

Critton, D. (2011) · doi:10.7301/z0f18wzs

Dominant Negative SHPTP2トランスジェニックマウスの作成

長谷川雅昭, Maegawa, H., 厚典, 柏., Sugai, S., & 吉川, 隆. (1997) · 糖尿病 · doi:10.11213/tonyobyo1958.40.115

Faculty Opinions recommendation of Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.

PIKE, L. J. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718087008.793485851

Data from Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance

Zhang, X., Maity, T. K., ROSS, K. E., Qi, Y., Cultraro, C. M., Bahta, M., Pitts, S., Keswani, M., Gao, S., Nguyen, K. D. P., et al. (2023) · doi:10.1158/0008-5472.c.6513445.v1

Data from SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy

Drilon, A. E. D. C., Sharma, M. R., Johnson, M. L., Yap, T. A., Gadgeel, S. M., Nepert, D. L., Feng, G., Reddy, M. B., Harney, A. S., Elsayed, M., et al. (2023) · doi:10.1158/2159-8290.c.6679570

Rôle de la protéine tyrosine phosphatase DEP-1 dans la régulation du programme angiogénique induit par le VEGF

Chabot, C. (2009) · doi:10.71781/28595

Cell Signaling by Hematopoietic Growth Factor Receptors

Starr, R., & Nicola, N. (1999) · Elsevier eBooks · doi:10.1016/b978-012624960-6/50004-2

Additional file 1 of Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cells

Kim, S.-M., Kwon, E.-J., Kim, Y.-J., Go, Y.-H., Oh, J.-Y., Park, S., Do, J. T., Kim, K.-T., & Cha, H.-J. (2022) · Figshare · doi:10.6084/m9.figshare.20336926

Activation de la phosphatase PTP SHP2 par le système de l'adrénomédulline dans les cellules endothéliales en vue d'une stabilisation vasculaire

Sigaud, R. (2017) · theses.fr (ABES) · doi:10.70675/522ce9cdzf7fbz4f40zaceaz3109efd79e4a

CLEC12B un gène de la famille des lectines impliqué dans le processus de melanomagénèse en agissant comme un gène suppresseur de tumeurs : CLEC12B un gène suppresseur de tumeurs impliqué dans le mélanome

Montaudié, H. (2019) · theses.fr (ABES) · doi:10.70675/f1484b7fz6f0bz40c7z928bz7df41933fe39

Impact de la protéine SHP2 associé au syndrome de Noonan sur le métabolisme glucidique

Paccoud, R. (2018) · theses.fr (ABES) · doi:10.70675/f9b9b046zdf4bz404fz9689z8deb20f6e5ac

Analyses moléculaire, cellulaire et fonctionnelle des protéines de signalisation CD5 et Themis1 dans les lymphocytes T

Blaize, G. (2018) · theses.fr (ABES) · doi:10.70675/ba42a77dze70az40fdzb9dez74c6f2241e7b

La plaquette sanguine : un nouvel acteur du syndrome hémorragique de Noonan et du développement des maladies métaboliques

Bellio, M. (2020) · theses.fr (ABES) · doi:10.70675/2226e8e5zcf59z4cc2zaf52z551806010983

Connective tissue growth in a mouse model of Kosaki overgrowth syndrome is limited by STAT1Preprint

Kim, J. H., Kwon, H. R., Berry, W. L., & Olson, L. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.09.717535 · Cited by 1

Discovery of DCAF16-based PROTACs as SHP2 degraders

Pang, X., Gan, Y., Hu, Q., Zheng, W., Liu, Y., Zhang, K., Yang, Y., Chen, L., & Li, H. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110372 · Cited by 1

Sequence space exploration in SHP2: mechanistic insights from disease-associated mutations

van Vlimmeren, A. E., Jiang, Z., Semoy, D. A., & Shah, N. H. (2026) · Biochemical Journal · doi:10.1042/bcj20250266

Structural and Functional Dissection of the Chemokine Receptor CCR7

Schäuble, K. (2011) · KOPS (University of Konstanz)

Protein dephosphorylation and protein phosphorylation

Gomperts, B. D., Kramer, I. M., & Tatham, P. E. R. (2002) · Elsevier eBooks · doi:10.1016/b978-012289631-6/50037-5

Phosphorylation of Tyrosine 720 in the Platelet-Derived Growth Factor α Receptor Is Required for Binding of Grb2 and SHP-2 but Not for Activation of Ras or Cell Proliferation

Bazenet, C. E., Gelderloos, J. A., & Kazlauskas, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6926 · Cited by 72

Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.

Lechleider, R. J., Sugimoto, S., Bennett, A. M., Kashishian, A., Cooper, J. A., Shoelson, S. E., Walsh, C. T., & Neel, B. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80562-6 · Cited by 319

The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp.

Kazlauskas, A., Feng, G., Pawson, T. J., & Valius, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6939 · Cited by 207

A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase

Li, W., Nishimura, R., Kashishian, A., Batzer, A., Kim, W. J. H., Cooper, J. A., & Schlessinger, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.509-517.1994 · Cited by 481

SHP-2 binds to Tyr763 and Tyr1009 in the PDGF β-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis

Rönnstrand, L., Arvidsson, A., Kallin, A., Rorsman, C., Hellman, U., Engström, U., Wernstedt, C., & Heldin, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202705 · Cited by 79